Assoc. Prof. Dr. Iulia Ioan | Medicine | Women Researcher Award

Assoc. Prof. Dr. Iulia Ioan | Medicine | Women Researcher Award

Assoc. Prof. Dr. Iulia Ioan | Medicine – University Hospital of Nancy, France

Dr. Iulia Ioan is a dedicated researcher specializing in pediatric respiratory medicine and sleep disorders. Her work focuses on advancing the understanding and clinical management of respiratory oscillometry, asthma, and obstructive sleep apnea in children and adults. Over recent years, she has established herself as a respected figure in her field, contributing to multidisciplinary collaborations that bridge clinical practice and functional respiratory research. Her continuous output of high-quality research articles and reviews reflects her commitment to improving respiratory health outcomes through innovative diagnostics and treatment strategies.\

Profile Verified:

ORCID | Scopus | Google Scholar

Education:

Dr. Ioan’s academic journey includes advanced medical and scientific training culminating in an MD and PhD, equipping her with a solid foundation in clinical medicine and biomedical research. Her specialized education in functional respiratory explorations has enabled her to develop expertise in pediatric respiratory function testing and clinical sleep medicine, which underpins her research endeavors.

Experience:

With substantial experience in clinical and research settings, Dr. Ioan currently serves at the Service d’Explorations Fonctionnelles Pédiatriques, Hôpital d’Enfants, CHRU de Nancy. Her role involves both direct patient care and leading research projects focused on pediatric respiratory diseases and sleep disorders. Over the years, she has honed skills in polysomnography, respiratory mechanics, and the evaluation of airway diseases, collaborating with national and international teams. Her involvement in translational research facilitates the implementation of novel diagnostic tools into routine clinical practice.

Research Interest:

Dr. Ioan’s research interests encompass respiratory oscillometry, pediatric asthma, sleep apnea syndromes, and the impact of environmental factors such as tobacco smoke on respiratory health. She explores the clinical applications of respiratory function testing technologies and their relevance in diagnosing and managing obstructive airway diseases. Additionally, her work addresses the epidemiology and treatment effectiveness of severe allergic asthma and sleep-related breathing disorders, contributing valuable insights into pediatric pulmonology and sleep medicine.

Awards:

While specific awards are not listed, Dr. Ioan’s profile demonstrates recognition through citations and sustained research output. Her work’s impact on clinical practice and respiratory medicine positions her as a strong candidate for research awards celebrating female scientists. Continued excellence in publication, collaboration, and clinical innovation further strengthens her candidacy for prestigious honors within respiratory and pediatric research communities.

Selected Publications:

  1. 🌬️ “Technical standards for respiratory oscillometry,” European Respiratory Journal, 2020. (Cited by 578) – This pivotal article defines technical guidelines widely used in respiratory function testing.
  2. 💤 “Clinical significance and applications of oscillometry,” European Respiratory Review, 2022. (Cited by 168) – A comprehensive review highlighting oscillometry’s role in respiratory disease assessment.
  3. 🌟 “Asthma and obstructive sleep apnoea in adults and children – an up-to-date review,” Sleep Medicine Reviews, 2022. (Cited by 65) – Integrates current knowledge on the overlap between asthma and sleep apnea.
  4. 🚭 “The impact of tobacco smoking on adult asthma outcomes,” International Journal of Environmental Research and Public Health, 2021. (Cited by 59) – Examines how smoking exacerbates asthma symptoms and treatment outcomes.
  5. 🛌 “Feasibility of parent-attended ambulatory polysomnography in children with suspected obstructive sleep apnea,” Journal of Clinical Sleep Medicine, 2020. (Cited by 31) – Demonstrates the practicality of home-based sleep studies for children.
  6. 🌿 “Real-life effectiveness of benralizumab, mepolizumab and omalizumab in severe allergic asthma associated with nasal polyps,” Clinical Reviews in Allergy & Immunology, 2023. (Cited by 30) – Evaluates biologic therapies for difficult-to-treat asthma.
  7. 🧒 “What is chronic cough in children?” Frontiers in Physiology, 2014. (Cited by 30) – Investigates the mechanisms and clinical implications of pediatric chronic cough.

Conclusion:

Dr. Iulia Ioan exemplifies the qualities of a committed and innovative researcher in pediatric respiratory and sleep medicine. Her robust publication record, focused research interests, and clinical expertise underline her significant contributions to advancing respiratory health. Dr. Ioan’s work not only enriches scientific understanding but also directly impacts patient care through improved diagnostics and treatment strategies. Given her ongoing research excellence, collaboration, and influence, she stands out as a highly deserving nominee for the Women Researcher Award, symbolizing dedication, impact, and leadership in her field.

 

 

 

Revathi | Healthcare | Best Researcher Award

Dr. Revathi | Healthcare | Best Researcher Award

Assistant Professor at Sona College of Technology, India

Dr. Revathi T.K. is an Assistant Professor in the Department of Computer Science and Engineering at Kongunadu College of Engineering and Technology, affiliated with Anna University, Chennai. With a deep-rooted interest in Information and Communication Engineering (ICE), Dr. Revathi completed her Ph.D. from Sona College of Technology, Salem, under the supervision of Dr. B. Sathiyabhama. Over the years, she has made significant contributions to the field, specializing in machine learning, cardiovascular disease prediction, and deep learning. Her academic journey has been marked by several accolades and a strong research portfolio.

Profile:

Google Scholar

Education:

Dr. Revathi T.K. holds a Ph.D. in Information and Communication Engineering (ICE) from Sona College of Technology, Salem, where her research was supervised by Dr. B. Sathiyabhama, with the thesis focusing on advanced machine learning techniques in healthcare. She completed her Master of Engineering (M.E.) in Computer Science and Engineering from Muthayammal Engineering College, Rasipuram, with distinction and a CGPA of 9.01. Prior to that, she earned her Bachelor of Engineering (B.E.) degree in the same field from Muthayammal Engineering College, achieving 81%. She also completed her schooling at Government Higher Secondary School, Namagiripettai, with top marks in both the HSC and SSLC exams, which laid a strong foundation for her academic pursuits.

Experience:

Dr. Revathi’s professional career spans over a decade, beginning as a Lecturer at Muthayammal Engineering College from June 2010 to May 2013. She then served as an Assistant Professor at Kongunadu College of Engineering and Technology from June 2013 to May 2018. Since August 2020, Dr. Revathi has been an Assistant Professor at Kongunadu College of Engineering and Technology, continuing to contribute to the field of engineering education and research. Her roles have included teaching core subjects, mentoring students, and guiding research, with an emphasis on integrating industry-relevant skills and technological advancements into the curriculum.

Research Interests:

Dr. Revathi’s research interests lie primarily in the domains of machine learning, deep learning, and healthcare applications, particularly in predictive models for cardiovascular diseases and other health-related issues. She has worked extensively on applying deep learning techniques to medical imaging, especially in retinal fundus images and coronary angiography, to diagnose conditions like cardiovascular disease and Parkinson’s disease. Her work also extends to the development of intelligent models for disease prediction, with a focus on improving diagnostic accuracy and efficiency using state-of-the-art techniques in artificial intelligence.

Awards:

Dr. Revathi has been recognized for her outstanding contributions to both academia and research. She was honored as a ‘Wipro Certified Faculty’ in 2019 by Wipro Technologies and received multiple awards for exceptional academic performance, including the Exceptional Performer Award for achieving 95% in the subject ‘Design and Analysis of Algorithms’. Furthermore, she has been acknowledged for her contributions to achieving 100% academic results in various subjects like ‘Software Quality Assurance’ and ‘User Interface Design’. Dr. Revathi was also awarded the Muthayammal Academic Award for excellent performance in the ‘Client Server Computing’ subject, and the Discipline Star Award from NPTEL.

Publications:

Dr. Revathi has authored several impactful research publications, including notable works such as:

  1. Revathi, T.K., Sathiyabhama, B., Kaliraj, S. et al. Early Prediction of Cardio Vascular Disease (CVD) from Diabetic Retinopathy using Improvised Deep Belief Network (IDBN), BMC Cardiovascular Disorders, 2025.

  2. A Machine Learning Approach for Predicting Parkinson’s Disease Using Big Data, Harish Reddy Gantla et al., Recent Advances in Management and Engineering, CRC Press, 2024.

  3. Revathi, T.K., Sathiyabhama, B., Vidhushavarshini S., and Seshathiri D. An Improved Long Short-Term Memory Algorithm for Cardiovascular Disease Prediction, Diagnostics, 2024.

  4. Revathi, T.K., Sathiyabhama, B., Sankar, S. et al. Diagnosing Cardiovascular Disease (CVD) using Generative Adversarial Network (GAN) in Retinal Fundus Images, Annals of the Romanian Society for Cell Biology, 2021.

  5. Revathi, T.K., Sathiyabhama, B., Sankar, S. A Deep Learning based Approach for Diagnosing Coronary Inflammation, Annals of the Romanian Society for Cell Biology, 2021.

Conclusion:

Dr. Revathi T.K. stands as a prominent academician and researcher in the field of Computer Science and Engineering, with a strong focus on artificial intelligence applications in healthcare. Her work has earned her several prestigious awards, and she has a proven track record of publishing in high-impact journals and contributing to the academic community. Dr. Revathi’s dedication to advancing both her students’ education and her research in machine learning for healthcare continues to inspire and lead by example, reinforcing her commitment to bridging the gap between technology and medical sciences for societal benefit.

YU LI | Medicine | Best Researcher Award

Ms. YU LI | Medicine | Best Researcher Award

Ms. YU LI | Medicine – Postgraduate student at Huazhong University of Science and Technology, China

Li Yu is an emerging researcher in the medical field with a strong academic background and practical experience in clinical practice and medical research. Currently working as a resident in training at a prominent hospital in Wuhan, Li Yu is also pursuing a master’s degree at a well-regarded university in the same city. With a keen interest in predictive modeling, clinical analysis, and health data science, Li Yu has demonstrated significant promise in the academic and clinical sectors. Their research contributions aim to improve patient care and hospital management, especially in the areas of mortality risk prediction and understanding apoptosis mechanisms. Through a combination of academic research and clinical work, Li Yu strives to contribute to both theoretical knowledge and practical advancements in the medical field.

Profile:

Orcid

Education:

Li Yu’s educational journey reflects a strong commitment to medical sciences. They completed a Bachelor’s degree in Medicine from Jianghan University, where they laid the foundation for a deeper understanding of healthcare. Following that, Li Yu enrolled in the master’s program at the same university to further specialize in medical research and clinical practice. This advanced education has allowed them to combine practical skills with research expertise, equipping them to tackle complex medical problems. In parallel to formal education, Li Yu has also taken on teaching assistant responsibilities, enhancing their understanding of medical topics and contributing to the academic development of other students.

Experience:

Li Yu’s career trajectory has been marked by a blend of practical experience in clinical environments and academic involvement. Since 2022, Li Yu has been a resident in training in the General Practice Department at the Central Hospital of Wuhan, where they gained hands-on experience in patient care, diagnostics, and treatment. This role has allowed Li Yu to apply their theoretical knowledge in real-world settings, gaining valuable insights into patient outcomes and healthcare management. Additionally, Li Yu has contributed as a teaching assistant at Jianghan University, where they assist in guiding medical students through various courses in the medical sciences. This combination of clinical and academic roles showcases Li Yu’s dedication to both patient care and knowledge dissemination in the medical field.

Research Interests:

Li Yu’s research interests lie at the intersection of clinical medicine and data science, with a focus on improving healthcare outcomes through predictive analytics and the study of cellular processes. One key area of interest is apoptosis and its signaling pathways, as understanding these processes could lead to breakthroughs in treating diseases such as cancer and neurodegenerative conditions. Another significant focus is predictive modeling for patient outcomes, particularly in emergency medicine, such as predicting the risk of mortality in patients who have suffered from sudden cardiac arrest. By combining data analysis with clinical insight, Li Yu aims to create models that can aid healthcare professionals in making better decisions and improving patient survival rates. Through their research, Li Yu seeks to bridge the gap between theoretical knowledge and its practical application in medical practice.

Awards:

While Li Yu is early in their research career, their contributions to the medical field have already gained recognition. Their ongoing research projects on predictive modeling and apoptosis have placed them in contention for various awards in the research community. Although Li Yu has not yet received major formal awards, their work demonstrates the potential for significant future contributions to healthcare research. Given their academic achievements and research accomplishments, Li Yu is a strong candidate for future awards as they continue to build a body of impactful work in the field of medicine.

Publications:

Li Yu has contributed to several notable research articles published in reputable medical journals, reflecting their active participation in advancing medical knowledge. Some of their key publications include:

  1. “A Visual Analysis of Global Research Trends in Signaling Pathways and Key Molecules within Pan-Apoptosis Studies” (Published 2024 in Journal of Cellular Biology). This article provides an in-depth analysis of global trends in apoptosis research, shedding light on emerging pathways and key molecules involved in the process. 🌍🔬
  2. “Establishing and Validating a Predictive Model for the Risk of In-Hospital Mortality After the Return of Spontaneous Circulation in Patients with Sudden Death” (Published 2024 in Journal of Emergency Medicine). This research focuses on creating a risk model for predicting in-hospital mortality, an important advancement in the field of emergency medical care. ⚠️🩺
  3. “构建并验证猝死患者复苏成功后院内死亡的风险预测模型——一项病例对照研究” (Published 2024 in Chinese Journal of Medicine). This study examines risk prediction models for patients who survive the initial stages of sudden cardiac arrest, providing critical insights into patient care post-resuscitation. 🫀📊

Conclusion:

Li Yu is a promising researcher who is making significant strides in both academic and clinical settings. Their research interests in predictive modeling and apoptosis, combined with hands-on clinical experience, position them as a potential leader in the field of medical research. Though still early in their career, Li Yu’s dedication to improving patient care and advancing scientific knowledge has already led to noteworthy publications and academic contributions. As their research continues to evolve, it is likely that they will have an even greater impact on the medical community, making them a deserving candidate for future awards and recognition in the research field.

Jun cheng | Public Health | Best Researcher Award

Prof. Jun cheng | Public Health | Best Researcher Award

director of dept. of key population | Chinese Center for Disease Prevention and Control | China

Dr. Jun Cheng is a prominent figure in tuberculosis (TB) prevention and control in China, currently serving as the Director of the Department of Key Population at the National Center for Tuberculosis Prevention and Control, Chinese Center for Disease Prevention and Control (China CDC). With a career spanning over three decades, she has dedicated her work to improving public health through rigorous research, training, and policy development focused on tuberculosis. Her role includes overseeing national initiatives on TB infection prevention, control in high-risk populations, and the establishment of protocols for TB prevention in congregate settings.

Profile

Orcid

Education:

Dr. Cheng earned her Master’s degree from the School of Public Health at Peking University, a prestigious institution known for its contributions to health sciences. Her educational background laid the foundation for her extensive career in public health, particularly in the fields of epidemiology and disease control, which has been instrumental in her work with China CDC and WHO.

Experience:

Dr. Cheng’s professional journey began in 1992 when she worked as a health statistics teacher and medical editor at North China Coal Medical College, where she honed her expertise in medical research and education. From 2004 to 2009, she worked as a professional researcher at the Beijing Institute of Cardiovascular and Pulmonary Diseases, focusing on epidemiological surveys and cardiovascular disease research. Since 2009, Dr. Cheng has been a key figure at the China CDC, where she has made significant contributions to TB prevention and control. As the Director of the Department of Key Population, she is responsible for developing national TB control programs, providing technical guidance, and leading initiatives for active case finding among high-risk populations. She has also played a key role in creating training courses for over 1,000 healthcare professionals annually.

Research Interests:

Dr. Cheng’s primary research interests lie in the field of tuberculosis prevention and control, particularly in infection control strategies and the impact of these strategies in congregate settings. She has made substantial contributions to the development of national and international TB guidelines, including the WHO Guidelines on Tuberculosis Prevention and Control. Her work focuses on identifying high-risk populations and ensuring that they receive effective TB prevention, diagnosis, and treatment. In addition to her work on TB, Dr. Cheng is also deeply interested in the broader public health implications of infectious diseases and the effectiveness of disease control measures across diverse healthcare settings.

Awards:

Dr. Cheng has received numerous accolades throughout her career for her exceptional contributions to public health and disease control. Her work, particularly in the field of TB prevention, has earned her recognition both in China and internationally. Notably, she was involved in the development of the WHO Tuberculosis Prevention and Control Guidelines, which are widely regarded as a cornerstone for global TB management. Dr. Cheng’s leadership in the TB BASICS project, which improved TB infection control in hospitals across multiple provinces, further underscores her commitment to improving healthcare infrastructure and disease prevention.

Publications:

  1. Cheng, J., et al. (2019). “WHO Guidelines on Tuberculosis Prevention and Control (2019 update).” WHO Bulletin.
  2. Cheng, J., et al. (2017). “Improving TB Infection Control in High-Risk Settings in China.” Journal of Epidemiology.
  3. Cheng, J., et al. (2018). “The Impact of Active Case Finding in Tuberculosis Control.” International Journal of Tuberculosis and Lung Disease.
  4. Cheng, J., et al. (2020). “TB Infection Prevention and Control in Congregate Settings.” Tuberculosis Research Journal.
  5. Cheng, J., et al. (2021). “Developing National Guidelines on Tuberculosis Prevention in China.” Chinese Journal of Disease Control.
  6. Cheng, J., et al. (2022). “Evaluation of TB Control Programs in High-Risk Populations.” Public Health Reports.
  7. Cheng, J., et al. (2023). “Training and Capacity Building in Tuberculosis Prevention.” Journal of Global Health.

Dr. Cheng’s work has been cited in numerous articles, highlighting the impact of her research on global and national health policies.

Conclusion:

Dr. Jun Cheng’s career stands as a testament to her dedication to public health, particularly in the fight against tuberculosis. Her leadership at the China CDC and her involvement in international TB guidelines have shaped the landscape of tuberculosis prevention and control. Through her research, training programs, and policy contributions, Dr. Cheng has made a lasting impact on both national and global health systems, working tirelessly to improve TB control efforts and safeguard public health for future generations.

Mircea Stoian | Health Professions | Excellence in Research

Assist. Prof. Dr. Mircea Stoian | Health Professions | Excellence in Research

University of Medicin, Pharmacy | Intensive Care Department | Romania

Dr. Mircea Stoian is a prominent Romanian specialist in anesthesiology and intensive care, with an extensive career in both clinical practice and academia. Born on October 29, 1971, he has dedicated his professional life to the improvement of patient care, particularly in critical care and anesthesia. As the head of the Anesthesia and Intensive Care Department at the Mureș County Clinical Hospital, he has been instrumental in advancing treatment protocols for patients with complex medical conditions. His expertise is backed by his experience as a lecturer at the University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, where he imparts critical care knowledge to the next generation of medical professionals.

Profile

Scopus

Education:

Dr. Stoian’s academic journey began at the University of Medicine and Pharmacy in Târgu Mureș, where he graduated with a degree in General Medicine in 1999. He then went on to specialize in Anesthesiology and Intensive Care, completing his residency at the Mureș County Emergency Clinical Hospital. He earned his medical doctorate in 2013, with a thesis on the study of renal permeability modification through electrofocusing post-anesthesia, under the supervision of Prof. Dr. Leonard Azamfirei. His pursuit of continuous professional development includes numerous certifications in ultrasound, healthcare management, and primary care.

Experience:

Dr. Stoian’s career spans both military and civilian healthcare sectors. Starting as a military physician in 2001, he later transitioned to clinical and academic roles. His clinical experience began at the Mureș County Clinical Hospital, where he rose through the ranks from specialist to senior physician. Over the years, he has gained expertise in complex anesthesia techniques, particularly in critical care settings. His leadership skills were further honed when he became the coordinator for the “Cyber-Physical Intensive Care Medical System for Covid-19” (ICU4COVID) study. He has also held key academic positions, including lecturer and senior physician at the University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, where he contributes to both teaching and research.

Research Interests:

Dr. Stoian’s primary research interests lie in anesthesiology, intensive care medicine, and the physiological mechanisms involved in critical illness. His doctoral thesis on renal permeability and protein electrofocusing after general anesthesia is a testament to his focus on the physiological aspects of anesthesia. He has also investigated the implications of gene polymorphisms in diabetes and neuropathies, as well as the clinical applications of ultrasound in anesthesiology. His research is particularly concerned with improving patient outcomes in intensive care units, focusing on critical care technology and its impact on patient survival and recovery.

Awards:

Dr. Stoian has been recognized for his contributions to the field of anesthesiology and intensive care. His work has earned him several academic distinctions and research grants. Notably, he was awarded the prestigious Postdoctoral Fellowship at the University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș in 2014. His innovative research in the development of cyber-physical systems for intensive care during the COVID-19 pandemic was widely acknowledged. He continues to be a leading figure in advancing medical technology and patient care standards within his field.

Publications:

Dr. Stoian has authored and co-authored numerous articles and books in the fields of anesthesiology, intensive care, and medical research. His contributions are primarily focused on the physiological effects of anesthesia, critical care methodologies, and neuropathic conditions in diabetic patients. Some of his notable publications include:

  1. “Vascular Endothelial Growth Factor Insertion/Deletion Gene Polymorphism in Patients with Type 2 Diabetes Mellitus and Diabetic Peripheral Polyneuropathy,” Revista Română de Medicină de Laborator, 2014, DOI: 10.2478/rrlm-2014-0023.
  2. “Influence of GSTM1, GSTT1, and GSTP1 Polymorphisms on Type 2 Diabetes Mellitus and Diabetic Sensorimotor Peripheral Neuropathy Risk,” Disease Markers, 2015, DOI: 10.1155/2015/638693.
  3. “Narrow-band imaging with magnifying endoscopy for the evaluation of gastrointestinal lesions,” World J Gastrointest Endosc, 2015, DOI: 10.4253/wjge.v7.i2.110.
  4. “No Association Between Antioxidant Enzyme Gene Polymorphism and Albuminuria in Type 2 Diabetes Mellitus Cases,” Revista de Chimie, 2016, DOI: 10.3390/diagnostics12123196.
  5. “Guillain-Barré Syndrome Associated with COVID-19: A Close Relationship or Just a Coincidence?” Experimental and Therapeutic Medicine, 2021, DOI: 10.3892/etm.2021.10616.

These publications have been cited in numerous studies, reflecting their impact on the scientific community.

Conclusion:

Dr. Mircea Stoian’s distinguished career in both clinical and academic medicine highlights his commitment to advancing medical knowledge and improving patient care. His extensive expertise in anesthesiology, intensive care, and medical research, coupled with his leadership in critical care systems, makes him a pivotal figure in his field. His ongoing research and publications continue to shape the future of intensive care medicine, and his contributions remain vital to the medical community’s response to complex health challenges.

Dr. Charles Gaillard | Health Professions | Best Researcher Award

Dr. Charles Gaillard | Health Professions | Best Researcher Award

Dr. Charles Gaillard, Centre Hospitalier Regional et Universitaire de Tours, France

Dr. Charles Gaillard is a dedicated urologist currently completing his medical training with a focus on transplantation and genitourinary oncology. He holds a series of advanced diplomas, including a Diplôme Inter-Universitaire in Oncologie Génito-Urinaire and a Thèse d’Exercice in Medicine, which he defended in 2022 on the topic of renal transplantation and drainage. Dr. Gaillard’s research, particularly his study on the necessity of drainage in renal transplantation, was published in FJUROL in August 2024 and awarded the Silver Medal with Honors from the jury. He has gained extensive clinical experience through internships at leading hospitals in Lyon and Tours, working under prominent professors in urology and vascular surgery.

Professional Profile:

Scopus

Suitability for the Award:

Dr. Gaillard’s research aligns well with the Best Researcher Award, especially given his focus on transplantation, surgical innovation, and urological treatment methodologies. His work contributes both to scientific understanding and practical advances in post-operative patient care, making a meaningful impact in his field.

Academic Background:

Dr. Charles Gaillard earned several prestigious diplomas in his field, including a Diplôme Inter-Universitaire in Genito-Urinary Oncology (2023), Thesis in Medicine on Renal Transplantation (2022), and Diplôme Universitaire in Urinary Lithiasis (2020). He has undergone specialized training in organ transplantation and urology across top institutions such as Sorbonne University and Paris-Lyon-Tours.

Clinical Experience:

Dr. Gaillard’s internship includes comprehensive work at Hôpital Edouard Herriot, Hôpital Bretonneau, and Clinique du Pôle Léonard de Vinci, where he honed his skills in urology, vascular surgery, and renal transplantation under expert supervision.

Research Focus & Achievements:

His doctoral thesis on renal transplantation—titled “Is Redon Drainage Essential in Renal Transplantation?”—was published in FJUROL (2024) and won the Silver Medal with Jury Honors. The study explored risk factors associated with the necessity of drainage in renal transplant surgeries.

Honors & Recognition:

Dr. Gaillard’s dedication to research and clinical excellence has earned him recognition in his field, including Medal of Silver with Jury Congratulations for his groundbreaking research on transplantation.

Publication Top Notes:

  • Cut-off time for surgery and prediction of orchiectomy in spermatic cord torsion: a retrospective multicentric study over 15 years
    • Journal: World Journal of Urology, 2023,
    • Citations: 2
  • Torsion of the spermatic cord in adults: a multicenter experience in adults with surgical exploration for acute scrotal pain with suspected testicular torsion
    • Journal: Asian Journal of Andrology, 2022,
    • Citations: 7
  • TORSAFUF – Surgical exploration for torsion of spermatic cord suspicion and risk factors for unnecessary surgery: Results of a French nationwide retrospective study on 2940 patients
    • Journal: Progres en Urologie, 2022
    • Citations: 2
  • Contralateral Orchiopexy at the Time of Urgent Scrotal Exploration-Is It Safe? A Propensity Score Matched Analysis from the TORSAFUF Cohort
    • Journal: Journal of Urology, 2021
    • Citations: 5

 

 

Hadi Shabanpour | Health Professions | Best Researcher Award

Mr . Hadi Shabanpour | Health Professions | Best Researcher Award 

PhD Student and Lecturer – The University of Queensland , SENV , Australia

Saeed Yousefi is a distinguished researcher from Tadbir Industry and Mining Development Group, Tehran, Iran. He specializes in innovative methods for healthcare systems, focusing on patient clustering and resource allocation using advanced data analysis techniques.

Profile

Scopus

Education

Saeed Yousefi holds extensive academic qualifications in the field of operations research and data analysis. His educational background underpins his expertise in applying sophisticated analytical methods to real-world problems in healthcare systems.

Experience

Saeed Yousefi has a significant track record in the industry, particularly in developing and implementing innovative patient clustering methods. His work aims to enhance the efficiency of healthcare systems by improving patient classification and resource allocation.

Research Interests

Saeed’s research interests revolve around healthcare analytics, specifically focusing on patient clustering methods and data-driven decision-making processes. His work often integrates advanced techniques such as Data Envelopment Analysis and Artificial Neural Networks to optimize healthcare delivery.

Award

Saeed Yousefi has been recognized for his innovative research with notable awards, reflecting his contributions to advancing healthcare analytics and improving patient care systems.

Publication

One of Saeed Yousefi’s significant publications is titled “An Innovative Patient Clustering Method Using Data Envelopment Analysis–Discriminant Analysis and Artificial Neural Networks: A Case Study in Healthcare Systems”. This article, co-authored with Reza Farzipoor Saen, Hadi Shabanpour, and Kian Ghods, was published in Socio-Economic Planning Sciences in 2024. It discusses a novel patient clustering approach using advanced data analysis techniques to enhance healthcare system efficiency. You can access the article here.

Conclusion

The research conducted by Saeed Yousefi, Reza Farzipoor Saen, Hadi Shabanpour, and Kian Ghods presents a pioneering and impactful approach to patient clustering and resource allocation in healthcare. The integration of DEA-DA with ANN models, particularly SOM, addresses a critical need for effective pandemic management and resource utilization. The practical implications and innovative nature of the research make it a strong candidate for the Best Researcher Award. However, further exploration into scalability, integration, long-term outcomes, and comparative analysis could enhance the robustness and applicability of the proposed method.

Yagmur Okcay | Pharnacology, Medical Pharmacology | Best Researcher Award

Ms.Yagmur Okcay | Pharnacology, Medical Pharmacology | Best Researcher Award

PhD Candidate/Research assistant PhD Candidate/Research assistant Turkey

Yağmur Okçay is a dedicated PhD Candidate and Research Assistant at the University of Health Sciences. With a background in pharmacy and a master’s in pharmacology, she is advancing her expertise in medical pharmacology. Her research efforts focus on neuropathic pain, cannabinoids, and behavioral pharmacology, contributing significantly to the field with multiple publications and collaborations.

profile

ORCiD

Education 🎓

Yağmur Okçay completed her undergraduate studies at Anadolu University Faculty of Pharmacy in 2019. She then pursued a master’s degree in Pharmacology. Currently, she is a PhD candidate in Medical Pharmacology at the University of Health Sciences, furthering her academic and research pursuits.

Experience 🏫

In her role as a research assistant at the University of Health Sciences, Yağmur has been actively involved in various research projects and academic endeavors. Her experience spans across multiple areas of pharmacology, where she has contributed to the understanding and development of new therapeutic strategies.

Research Interests 🔬

Yağmur’s research interests are primarily focused on neuropathic pain, behavioral pharmacology, cannabinoids, and the autonomic nervous system pharmacology. Her work aims to elucidate complex biochemical pathways and explore novel therapeutic applications for various pharmacological challenges.

Awards 🏆

Yağmur Okçay’s contributions to pharmacology have been recognized through her active involvement in significant research projects and publications. While specific awards are not mentioned, her nomination for the Best Researcher Award reflects her dedication and impact in the field.

Publications 📄

  1. Dynamic Endocannabinoid-mediated Neuromodulation of Retinal Circadian Circuitry (2024) – Ageing Research Reviews
    • Cited by articles in various pharmacology and neuroscience journals.
  2. Additional publications include 5 research articles and 2 review articles in SCI/SCIE indexed journals, showcasing her extensive research output and scholarly impact.

Shreyas Yakkali | Medicine and Dentistry | Best Researcher Award

Mr. Shreyas Yakkali | Medicine and Dentistry | Best Researcher Award

Resident at Jacobi Medical Center – – Bronx, NY, United States

Dr. Shreyas Yakkali is an accomplished medical professional with a robust background in internal medicine and healthcare research. Currently pursuing his Internal Medicine PGY-1 at Jacobi Medical Center/Albert Einstein College of Medicine, he holds an M.B.B.S. (MD Equivalent) from GS Medical College & KEM Hospital, Mumbai. Dr. Yakkali’s career spans extensive international experience, including roles as an Emergency Medical Officer at Fortis Healthcare in India and various clinical observer positions in the United States. His research prowess is evident through multiple collaborations and publications, focusing on clinical trials, observational studies, and literature synthesis. Driven by a commitment to ethical patient care and continuous professional growth, he actively contributes to medical literature and community service initiatives. Dr. Yakkali’s holistic approach combines clinical expertise with rigorous research skills, making him a valuable asset in advancing healthcare practices.

Professional Profiles

Education

Dr. Shreyas Yakkali has pursued a diverse and comprehensive educational journey, beginning with his foundational education at St. Pius X High School. He continued his academic pursuit at Pace Institute of Technology & Sciences for his junior college education, laying the groundwork for his future in medicine. Dr. Yakkali achieved his M.B.B.S. (MD Equivalent) degree from GS Medical College & KEM Hospital in Mumbai in June 2021, marking a significant milestone in his medical training. Currently, he is furthering his specialization through the Internal Medicine PGY-1 residency program at Jacobi Medical Center/Albert Einstein College of Medicine, where he continues to expand his clinical knowledge and expertise. His educational path reflects a commitment to excellence in healthcare and a dedication to continuous learning and professional growth in the medical field.

Professional Experience

Dr. Shreyas Yakkali is an Internal Medicine Resident at Jacobi Medical Center/Albert Einstein College of Medicine, actively engaged in patient care and medical education. With prior experience as an Emergency Medical Officer at Fortis Healthcare in Mumbai, he has demonstrated proficiency in acute care and emergency medicine. His research collaborations at McMaster University and the California Institute of Behavioral Neurosciences have enriched his expertise in behavioral neuroscience and clinical trials. Driven by a passion for advancing medical knowledge, Dr. Yakkali aims to deliver compassionate and evidence-based care, leveraging his diverse experiences to contribute effectively to the healthcare field.

Research Interest

Dr. Shreyas Yakkali’s research interests encompass several facets of internal medicine and clinical research. He is particularly focused on advancing knowledge in acute care medicine, emergency medicine, and behavioral neuroscience. His collaborations at McMaster University and the California Institute of Behavioral Neurosciences have sparked his interest in clinical trials, with a keen emphasis on understanding neurological disorders and their treatment outcomes. Dr. Yakkali is dedicated to exploring innovative approaches in patient care, including the integration of new technologies and therapies. His research endeavors aim to enhance medical practices, improve patient outcomes, and contribute valuable insights to the field of healthcare.

Award and Honors

Dr. Shreyas Yakkali has been recognized for his outstanding achievements and contributions in the field of healthcare and medical research. He was awarded the prestigious Summa honor for publishing high-quality research in the Cureus Journal in 2022. Additionally, he holds certifications in Advanced Cardiovascular Life Support (ACLS) and Basic Life Support (BLS) for Healthcare Providers from the American Heart Association, obtained in 2023. His ECFMG certification in 2021 signifies his proficiency in medical knowledge and clinical skills, essential for practicing medicine internationally. These honors underscore Dr. Yakkali’s dedication to advancing medical education, conducting impactful research, and delivering high standards of patient care throughout his career.

Research Skills

Dr. Shreyas Yakkali possesses a diverse set of research skills that contribute to his proficiency in medical and healthcare research. His expertise includes literature review and synthesis, evidenced by his publications in reputable journals. He is adept at clinical trial methodologies and Good Clinical Practice (GCP), ensuring rigorous ethical standards in research conduct. Dr. Yakkali excels in data analysis and interpretation, employing statistical tools to derive meaningful insights from research data. His ability to design and execute research protocols is complemented by his hands-on experience in observational studies and collaborative research projects across various healthcare settings. Furthermore, his skills extend to manuscript preparation and academic writing, reflecting his commitment to disseminating research findings effectively. Dr. Yakkali’s research skills underscore his role as a dedicated scholar and practitioner contributing to advancements in internal medicine and healthcare practices.

Publications

  1. Adaptation to heat stress: a qualitative study from Eastern India
    • Authors: A.K. Khetan, S. Yakkali, H.H. Dholakia, V. Hejjaji
    • Journal: Environmental Research Letters, 2024
    • Volume: 19(4)
    • Pages: 044035
    • Citations: 0
  2. The burden of premature adult mortality associated with lack of access to electricity in India
    • Authors: V. Hejjaji, D. Barbhaya, A. Rahimian, S. Yakkali, A.K. Khetan
    • Journal: PLoS ONE, 2024
    • Volume: 19(3 March)
    • Pages: e0297463
    • Citations: 0
  3. Precision medicine in Myocardial Infarction With Non-obstructive Coronary Disease (MINOCA): A comprehensive review
    • Authors: L. Fatima, A. Goyal, S. Yakkali, A.H. Sohail, J. Malik
    • Journal: Current Problems in Cardiology, 2024
    • Volume: 49(2)
    • Pages: 102185
    • Citations: 1
  4. The burden of premature mortality from coal-fired power plants in India is high and inequitable
    • Authors: D. Barbhaya, V. Hejjaji, A. Vijayaprakash, A.K. Khetan, A. Muralidharan, S. Yakkali
    • Journal: Environmental Research Letters, 2022
    • Volume: 17(10)
    • Pages: 104022
    • Citations: 2
  5. Reasons for Non-Referral for Autologous Stem Cell Transplantation in Central Nervous System Lymphoma (CNSL) Patients in a Minority-Rich, Multiracial, and Underprivileged Population at Montefiore Medical Center, Albert Einstein College of Medicine
    • Authors: H. Narvel, S. Yakkali, A.-H. Bazarbachi, I. Braunschweig, R.A. Sica
    • Journal: Clinical Lymphoma, Myeloma and Leukemia, 2022
    • Volume: 22
    • Pages: S362
    • Citations: 0
  6. Do Certain Biomarkers Predict Adverse Outcomes in Coronavirus Disease 2019?
    • Authors: H. Narvel, A. Sayed, N. Narvel, S. Yakkali, T. Katchi
    • Journal: Journal of Clinical Medicine Research, 2021
    • Volume: 13(4)
    • Pages: 195–203
    • Citations: 2